Thermi®‘s temperature controlled RF system is indicated:
• In the United States for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.
• In Europe for electrocoagulation of soft tissues for vulvovaginal laxity.
Important Safety Considerations:
Thermi radiofrequency products should not be used on patients who are pregnant, have a fever or skin infection in or around the area of treatment. Expected procedure side effects may include transient pain in the procedure area, erythema and edema.